Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruboxistaurin for vision loss in diabetic retinopathy (PKC-DRS2)
NCT00604383Phase 3Completed
- Sponsor
- Chromaderm
- Start
- Mar 2001
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ruboxistaurin in diabetic retinopathy (DR), sponsored by Chromaderm. Started Mar 2001; status: completed.
02
Drugs
ruboxistaurin
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT00604383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00604383.